Market revenue in 2023 | USD 2,557.4 million |
Market revenue in 2030 | USD 8,502.1 million |
Growth rate | 18.7% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 62.95% in 2023. Horizon Databook has segmented the South Korea non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is the 8th largest aesthetic market in the world having the highest number of aesthetic procedures per capita globally, with 600+ clinics in Seoul alone. Key market drivers include rising medical tourism in South Korea, increasing public awareness about cosmetic procedures, availability of technologically advanced products, increasing geriatric population, and presence of extremely beauty conscious individuals.
The advent of new technology is also expected to boost adoption of new cosmetic procedures, and cosmetic treatment cost in South Korea is approximately 40% to 80% lower than that in other countries. Thus, thousands of people travel to the country every year to undergo various surgical and non-surgical procedures.
The cost of treatment in South Korea is less as compared to the U.S., Japan, and China, which is a contributing factor for the growth of non-invasive aesthetic treatment market. Aesthetic regulations in Korea are not very stringent and there are a diverse range of treatment options for noninvasive procedures.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Korea non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account